Adrenergic Agonists

Adrenergic Agonists Study Notes

Overview of Adrenergic Agonists

  • Adrenergic agonists are drugs that mimic the action of neurotransmitters by binding to adrenergic receptors in the body.
  • They play a crucial role in various physiological processes, including cardiovascular, respiratory, and metabolic functions.

Key Concepts

Adrenergic Neurons
  • Synthesis of Norepinephrine (NE):
    • Norepinephrine is synthesized from the amino acid tyrosine, obtained from the diet.
    • Tyrosine is taken up by adrenergic neurons via sodium co-transporters.
    • Tyrosine is converted to L-DOPA, then to dopamine, and finally to norepinephrine via specific enzymes in vesicles.
Release Mechanism
  • Exocytosis Process:
    • The release of NE occurs via exocytosis when action potentials stimulate voltage-gated calcium channels.
    • Calcium influx triggers the fusion of NE-containing vesicles with the neuronal membrane, releasing NE into the synaptic cleft.
  • Receptor Binding:
    • Released NE binds to adrenergic receptors, exerting effects based on their location and type (alpha or beta receptors).
Types of Adrenergic Receptors
  • Alpha-1 Receptors:
    • Activate phospholipase C pathway -> Increase in IP3 and diacylglycerol -> Raise intracellular calcium levels -> Smooth muscle contraction (e.g., blood vessels, sphincters).
  • Alpha-2 Receptors:
    • Activate adenylate cyclase pathway (G-inhibitory) -> Decrease cyclic AMP levels -> Inhibit secretion of neurotransmitters/hormones.
  • Beta-1 Receptors:
    • Activate adenylate cyclase pathway (G-stimulatory) -> Increase cyclic AMP levels -> Increase heart rate and contractility (heart and kidneys).
  • Beta-2 Receptors:
    • Similar to beta-1 but mainly induce relaxation in smooth muscles (e.g., vasodilation in skeletal muscle blood vessels, bronchodilation).
  • Beta-3 Receptors:
    • Found in adipose tissue and the bladder detrusor muscle, leading to relaxation of the detrusor muscle and inhibition of urination.

Reuptake and Metabolism of Norepinephrine

  • After exerting its effects, NE can be degraded or recycled:
    • Catechol-O-methyl transferase (COMT): Degrades NE into inactive metabolites, usually excreted in urine.
    • Norepinephrine reuptake transporter (NET): Recycles active NE back into the presynaptic neuron for reuse.
    • Monoamine oxidase (MAO): Enzyme degrading norepinephrine, particularly in mitochondria.

Types of Adrenergic Agonists

1. Direct-Acting Agonists
  • Bind directly to adrenergic receptors and mimic NE/epinephrine effects.
    • Examples: Norepinephrine, epinephrine.
2. Indirect-Acting Agonists
  • Increase norepinephrine availability without directly binding to receptors.
    • Examples: Cocaine (inhibits NE reuptake), amphetamines.
3. Mixed Agonists
  • Both stimulate receptors and increase norepinephrine levels.
    • Examples: Pseudoephedrine (nasal decongestant), Ephedrine.

Effects of Norepinephrine and Epinephrine on Receptors

  • Alpha-1 Receptor Effects:
    • Blood vessel constriction -> Increased systemic vascular resistance and blood pressure.
    • Inhibition of urination (sphincter contraction).
  • Alpha-2 Receptor Effects:
    • Inhibition of further NE release and secretion of insulin.
  • Beta-1 Receptor Effects:
    • Increased heart rate and contractility -> Increased cardiac output.
  • Beta-2 Receptor Effects:
    • Vasodilation in blood vessels supplying heart and skeletal muscles -> Decreased systemic vascular resistance and blood pressure.
    • Bronchodilation in lungs.
  • Beta-3 Receptor Effects:
    • Detrusor muscle relaxation -> Inhibition of urination.

Adrenergic Agonist Drugs and Clinical Uses

Alpha-1 Agonists
  • Phenylephrine:
    • Use in hypotension, shock states, and to induce pupil dilation for ophthalmic procedures.
  • Midodrine:
    • Effective in treating orthostatic hypotension by increasing venous return and blood pressure.
Alpha-2 Agonists
  • Clonidine:
    • Used for hypertension and ADHD. Can cause sedation and lethargy.
  • Alpha-Methyl dopa:
    • Safe antihypertensive for pregnant women.
Beta-1 Agonists
  • Dobutamine:
    • Primarily used for heart failure and bradycardia, increasing heart rate and contractility.
Beta-2 Agonists
  • Albuterol:
    • Short-acting, used for acute asthma and COPD treatment.
  • Salmeterol:
    • Long-acting for chronic asthma management.
  • Terbutaline:
    • Used in severe asthma or as a tocolytic to inhibit prematurity.

Key Adverse Effects to Monitor

  • Bradycardia/Tachycardia:
    • Norepinephrine can induce reflex bradycardia; keep an eye on heart rate changes in patients receiving adrenergic agonists.
  • Hyperglycemia:
    • Especially relevant with beta-2 agonists due to increase in glucose release from the liver. Monitor in diabetic patients.
  • Tremors:
    • Commonly associated with beta-2 agonists.

Interpretation of Hemodynamic Graphs

  • Norepinephrine:
    • Slight decrease in heart rate (reflex bradycardia), increase in systolic and diastolic BP, neutral cardiac output, increase in systemic vascular resistance.
  • Epinephrine:
    • Increased heart rate, increase in systolic blood pressure, slight decrease in diastolic blood pressure, increased cardiac output, and moderate increase in mean arterial pressure.
  • Isoproterenol:
    • Increased heart rate, increased cardiac output, increase in systolic blood pressure, decreased diastolic pressure (due to vasodilation), leading to low systemic vascular resistance
Conclusion
  • Understanding the mechanisms of adrenergic agonists provides important insights into their clinical applications and effects on the body.
  • Data on specific adrenergic receptors are essential for effective treatment strategies in various medical conditions.